PPAR-γ plays a critical role in glucose homeostasis and is a molecular target of insulin sensitizing drugs called thiazolidinediones which are PPAR-γ ligands ^(3). PPAR-γ ligands also upregulate expression of adipocyte glycerol kinase, resulting into improved insulin action in target tissue such as liver and muscle ^(4). PPAR-γ ligand also shown to augment glucose disposal in peripheral tissues by increasing expressions of the glucose transporter genes, GLUT-1 and GLUT-4⁽⁵Majority of the Diabetes Mellitus Type 2 (DM type 2) patients (80%) are obese, but all obese persons do not develop DM type 2. Serum adiponectin level should be determined by level of PPAR-γ activity in adipocytes.

Therefore it will be of interest to explore the difference in the level of serum PPAR-γ level between obese subjects with DM-2 and without DM-2, as both the insulin sensitizing factor’s adiponectin, and vistafin are synthesized in response to FFA. PPAR-γ complex receptor activity.

Estimation of serum PPAR- level alongwith FBG was done in 90 cases, of which 30 were normal healthy subjects, 30 obese without diabetes type 2 and 30 obese with diabetes type 2 . The qualitative estimation of PPAR-γin human serum was done by ELISA method using ELISA kit from E lab science Biotechnology co.ltd. In our study we found a significant change in the level of PPAR-between the obese with DM-2 and control subject and also between obese without DM-2 and control subject but we did not find any significant difference between obese with DM-2 and obese without DM-2

In our present study we found the Increased Levels of PPAR- in the Obese without Diabetes Mellitus and Obese with Diabetes Mellitus. The levels were 8.03ng/ml ±11.16 and 8.04ng/ml±10.94 respectively.

Finally, we observed that the level of PPAR- is increased with both the groups,i.e .obese without DM-2 and obese with DM-2 in comparison to normal subjects.

 1.      Harrison Principles of Internal Medicine 18^th Edition Volume 1& 2

2.      Eckel R., Grundy S. Insensitivity to insulin and obesity: the underlying cause, Diabetes Voice 2006; 51;28-30

3.      Berger J.Leibowitz MD Doebber TW, et al. novel PPAR – γ & PPAR – δ ligands produce distinct biological effect. J bill Chem 1999; 274:6718-6725.

4.      Gurnell, M.,  2003. PPAR  - γ Modulation of Insulin Sensitivity – Potential Mechanisms. Clin Endocrinology. 59 (3)

5.      Sokkar, S. Jehan, A. , E1 – Sharnouby et al 2009. Role of PPAR  - γ, Gene Polymorphism in Type 2 Diabetes Mellitus. European Journal of General Medicine 6 (2): 78-86.

6.      Borroso  I ,Gurnell M, Crowley VE et al. Dominant negative mutations in human PPAR – γ associated with , severe insulin resistance, DM, & HTN. Nature 1999;402:880-883.

7.      Schonfeld,G. (1994) The effects of fibrates on lipoprotein and hemostatic risk factors. Atherosclerosis, 111, 161-174.

8.      OsumiT.. Wen.J.K. and Hashimoto,T. (1991) Two cis-acting regulatory elements in the peroxisome proliferator-responsive element enhancer region of rat acyl-CoA oxidase gene. Biochiemii. Biophys. Res. Com11u711n1.a.175, 866-871.

9.      Kliever.S.A.. Forman.B.M.. Blumberg.B.. Ong.E.S.. Borgmeyer.U.. Mangelsdorf. D.J.. Umesono.K. and Evans.R.M. (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl Acald. Sci. USA. 9. 7355-7359.

10.  Maegawa,H._ Ide.R.. Hasegawa.M.. Ugi,S.. Egava.K., Iwanishi.M.. Kikkawa,R., Shigeta.Y. and Kashigawa,A. (1995) Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities. J. Biol. Chem..  270. 7724-7730.

11.  Tontonoz,P., Hu,E. and Spiegelman,B.M. (1994b) Stimulation of adipogenesis in fibroblasts by PPARy2, a lipid-activated transcription factor. Cell, 79, 1147-1156.

12.  Tontonoz,P., Hu,E., Devine,J., Beale,E.G. and Spiegelman,B.M.(1995)

13.  PPARy2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol., 15, 351-357.

14.  Brun,R.P., Tontonoz,P., Forman,B.M., Ellis,R., Chen,J., Evans,R.M. and Spiegelman,B.M. (1996) Differential activation of adipogenesis by  multiple PPAR isoforms. Genies Dei., 10, 974-984.

15.  Lehman.J.M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor y and promotes adipocyte differentiation. Cell, 83. 813-819.

16.  Staels,B., Vu-Dac,N., Kosykh,V., Saladin,R., Fruchart,J.C., Dallongeville,J. and Auwerx,J. (1995) Fibrates down-regulateapolipoprotein C-1Il expression independent of induction ofperoxisomal acyl co-enzyme A oxidase. J. Clin. Invest., 95, 705-712

Dr Manish Malhotra

JR-III, MD (Biochemistry), Department of Biochemistry, SRMS IMS, Bareilly

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.